Thanks for visiting Scientific Computing World.

You're trying to access an editorial feature that is only available to logged in, registered users of Scientific Computing World. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Abbott to acquire Starlims Technologies

Share this on social media:

Global healthcare company Abbott is to acquire LIMS supplier Starlims Technologies for approximately $123m in cash.

The acquisition strengthens Abbott's competitive position in the global diagnostics market, providing advanced web-based applications to help laboratories efficiently store, retrieve and analyse a significantly increasing volume of clinical, managerial and administrative data.

'The acquisition of Starlims will provide Abbott with leading products to build upon existing technologies and expertise in the emerging field of healthcare informatics,' said Edward Michael, executive vice president, Diagnostics Products, Abbott. 'Starlims' advanced web-based technologies can help our customers operate efficiently across the core laboratory, molecular and point-of care segments of the global diagnostics market.'

As Abbott integrates Starlims into its existing portfolio of laboratory information management products, the company will continue to support and expand the non-clinical market segments currently served by Starlims.

'We believe our laboratory information management solutions, which are widely used by government, manufacturing and life sciences organisations, have important applications in clinical laboratories for improving the access, exchange and analysis of patient and technical data,' said Itschak Friedman, chief executive officer of Starlims, who will continue to lead the Starlims team after the acquisition closes. 'We look forward to becoming a part of Abbott and working together to serve our current customers and expand the availability of our technologies to address unmet needs in laboratories around the world.'